Research-Grade vs Cosmetic-Grade Peptide Raw Materials: What the Words Actually Mean

"Grade" sounds like a specification. For peptide raw materials it is not one. No pharmacopoeia defines a research grade or a cosmetic grade of Copper Tripeptide-1, no regulator certifies either, and two suppliers using the same word can mean different things. What the word actually encodes is a bundle: which documents travel with the powder, what the seller says it is for, how it is packed, and who is allowed to buy it.

This guide unpacks that bundle so you can read a listing and know what you are getting: what a research-grade listing usually means, what a cosmetic raw-material listing should carry, what neither of them is, why the same molecule is sold both ways from one production line, what you must still do in each market, what the certificate of analysis does not prove, and the questions worth asking a supplier before the first 5 g arrives.

Grade is a set of documents, an intended use and supply conditions

Three things make a listing research-grade or cosmetic-grade. None of them is the molecule.

• Documents. A certificate of analysis, a safety data sheet, an identity statement naming the INCI entry and the CAS number, a storage and retest statement, a manufacturer's name and address.
• Intended use. What the seller says the material is for, on the label, the listing and the paperwork. A research-use-only statement and a cosmetic raw-material statement point to different buyers and different obligations, and a regulator reads them literally.
• Supply conditions. Format (vial or bulk), quantity, who the seller will sell to, and how the material is shipped and stored.

Purity is not on that list on purpose. A research vial and a cosmetic bulk lot from the same manufacturer can and often do show the same HPLC purity, because they came off the same column. Peptide raw materials for cosmetics have no monograph; the specification is whatever buyer and manufacturer agree, and the COA reports against it.

What a research-grade listing usually means

Research-grade peptides are sold to laboratories for in-vitro and analytical work. The listing usually looks like this.

• A research-use-only statement, paired with a statement that the material is not for human or veterinary use as supplied.
• Vial format. Lyophilised powder in a glass vial at milligram scale. Convenient for a laboratory, awkward for a bench that wants to weigh a few hundred milligrams into a beaker.
• HPLC purity and MS identity. Reverse-phase HPLC purity as an area percentage and a mass-spectrometry molecular-weight check. Water content, counter-ion and residual solvent are often not reported.
• Common-name labelling. The vial says GHK-Cu, not Copper Tripeptide-1. The CAS number may be that of the copper-free ligand, the complex, or absent.
• No SDS, or a generic one that does not follow the GHS section structure.
• A laboratory as the buyer, often through a trading company, so the manufacturer's address may not appear anywhere.

None of this makes research-grade material worse. For an analytical standard or a cell-culture experiment it is the right package. It is the wrong package for a product information file, because the documents a safety assessor needs are not in it.

What a cosmetic raw-material listing should carry

A cosmetic raw material goes into a product that will be placed on a market, and the listing has to support the file that market requires. At a minimum it should come with the following.

1. The INCI name as it appears in the cosmetic ingredient nomenclature, so the label declaration and the ingredient check use the same words. Where no INCI name exists, as for Epitalon, the listing should say so rather than invent one.
2. A CAS number that matches the INCI entry. For Copper Tripeptide-1 two numbers circulate: 89030-95-5 for the copper complex and 49557-75-7 for the copper-free ligand. The number on the COA should match the material in the jar and the entry you declare; if it does not, ask why before you file anything.
3. A safety data sheet in GHS format. The sixteen-section structure, in a language your assessor reads, naming the substance, the manufacturer and the hazard classification. OSHA's Hazard Communication Standard, for example, specifies this format.
4. A lot certificate of analysis. Lot number, manufacture and test dates, appearance, HPLC purity, MS identity, and any further tests your specification calls for: water content, counter-ion, residual solvents, heavy metals, microbial limits.
5. The manufacturer's name and address on the COA and the SDS, so the responsible person can name the source of the ingredient.
6. Storage condition and retest date printed on the COA, so your goods-in record and retest schedule start from the supplier's figure.
7. A cosmetic-use statement: supplied as a cosmetic raw material and for laboratory formulation work, not for human or veterinary use as supplied.
8. No medical positioning. No wording on the listing, the label or the COA that describes the material as acting on a condition.

Bulk format follows from the use. A formulator weighs grams, not milligrams, so the material is supplied as powder in a sealed container, from 5 g, with the lot documents attached to that container.

What neither grade is

Neither is a drug-substance grade. A research vial and a cosmetic bulk lot are both chemical raw materials with an identity and purity certificate. Neither carries the manufacturing documentation, the validated process and the regulatory filing that define an active substance for a medicine. Neither grade implies a GMP claim, and Pepti does not present itself as a cGMP drug-substance manufacturer.

Neither implies a market authorisation. Buying cosmetic-grade Copper Tripeptide-1 does not make your serum compliant anywhere. The documents support your file; they are not a file. The ingredient check, the safety assessment, the notification or listing and the claims substantiation belong to the person placing the finished product on the market, in each market separately.

Both statements hold for every compound on this site and are printed on each ingredient page as a boundary. Sourcing conversations keep drifting towards "is it certified", and the honest answer is that a peptide raw material is documented, not certified.

Side by side

	Research-grade listing	Cosmetic raw-material listing
Naming	Common or code name (GHK-Cu)	INCI name (Copper Tripeptide-1) with a matching CAS
Identity documents	COA with HPLC purity and MS identity	Lot COA with HPLC purity, MS identity, appearance, storage and retest, plus tests in the buyer's specification
Safety documents	None, or a generic sheet	SDS in the GHS sixteen-section format, naming the manufacturer
Manufacturer identity	Often a trading company; address may be absent	Manufacturer name and address on COA and SDS
Format	Lyophilised powder in milligram-scale vials	Bulk powder in a sealed container
Typical quantity	Single vials or small kits	From 5 g; a 10-vial sample kit is possible as a first order
Use statement	Research use only; not for human or veterinary use as supplied	Cosmetic raw material and laboratory formulation work; not for human or veterinary use as supplied
Positioning	Described by the literature it is studied in	Described by identity and properties; no medical wording
Buyer	Laboratories and research institutions	Formulators, contract manufacturers and brand owners with a responsible person
Storage and shipping	Cold, stated on the vial label	Cold-chain shipping; storage and retest on the lot COA

Same molecule, two listings: GHK-Cu as the worked example

Copper Tripeptide-1 shows how one molecule becomes two products. Pepti, Guangzhou synthesises the tripeptide glycyl-L-histidyl-L-lysine, forms the copper complex, purifies it by preparative HPLC and lyophilises it. Up to that point there is one material, with one purity, one mass-spectrometry identity and one CAS number, 89030-95-5.

What happens next decides the grade. Part of the lot is filled into vials at milligram scale, labelled GHK-Cu, documented with a vial COA carrying a research-use-only statement, and sold to laboratories. The rest stays as bulk powder in sealed containers, is documented with a lot COA naming Copper Tripeptide-1 and the CAS of the complex, carries storage and retest on the certificate and an SDS in GHS format, and is sold to formulators from 5 g, shipped cold-chain.

Peptiraw lists only the second of those. Research-use supply of the same molecules is handled separately by the manufacturer, and nothing on this site is written for it. The public batch records in the Pepti COA library at peptioem.com/coa are vial-format records from the research side; they are useful because they show what the manufacturer's HPLC purity looks like lot by lot, and the published figures currently fall between 98.4% and 99.8%. The bulk-powder lot you receive carries its own COA with its own lot number, and that is the document for your product information file.

PubChem keeps the two GHK identities apart: the copper complex is CID 71587328, titled Prezatide copper, formula C14H23CuN6O4 (PubChem CID 71587328), and the copper-free tripeptide is CID 73587, glycyl-L-histidyl-L-lysine, C14H24N6O4 (PubChem CID 73587).

What you must still do with a cosmetic-grade material in each market

Buying the right document set is the start of the compliance work, not the end. The outline below describes the main steps in words, for orientation; it is not legal advice. The official pages linked are where to read the actual requirements.

European Union

• Ingredient check. Confirm the INCI name in the Commission's CosIng database and check whether the substance appears in any annex of the Cosmetics Regulation.
• Safety assessment and CPSR. A qualified safety assessor reviews the finished product and writes the cosmetic product safety report. The raw-material COA, SDS and any impurity data feed into it.
• Product information file. The responsible person keeps the PIF, holding the product description, the CPSR, the manufacturing method and the compliance statement the Regulation asks for.
• Notification, labelling and claims. The product is notified through the Cosmetic Products Notification Portal before it is placed on the market; the ingredient list uses INCI names; claims are substantiated.

The responsible person, the safety assessment and the product information file are set out in Regulation (EC) No 1223/2009 on cosmetic products, Articles 4, 10 and 11 (EUR-Lex, Regulation (EC) No 1223/2009). The Commission describes the CPNP as the free online notification system implementing that Regulation (European Commission, Cosmetic Product Notification Portal) and publishes the ingredient inventory as CosIng (European Commission, CosIng).

United States

• Intended use. Whether the finished product is a cosmetic depends on its intended use as shown by claims and marketing.
• Facility registration and product listing. Under MoCRA, facilities that manufacture or process cosmetics register with FDA and renew on the cycle FDA sets, and the responsible person lists each marketed product with its ingredients and updates the listing annually.
• Safety substantiation and adverse events. The responsible person holds records showing adequate substantiation of safety and reports serious adverse events within the period MoCRA sets. The raw-material documents are part of that record, not the whole of it.

FDA's MoCRA page describes the Modernization of Cosmetics Regulation Act of 2022 as adding facility registration, product listing, safety substantiation, serious adverse event reporting and fragrance allergen labelling to the agency's cosmetic authorities (FDA, Modernization of Cosmetics Regulation Act of 2022), and its page on product classification states that legal status is determined by intended use (FDA, how intended use determines whether a product is a cosmetic).

Other markets

Mainland China keeps an inventory of ingredients already used in cosmetics, and a peptide absent from it goes through a new-ingredient route before a product containing it can be sold there. Other markets run on prohibited and restricted lists closer to the EU model.

What a cosmetic-grade COA does not prove

The lot certificate of analysis is the most useful document in the set and the most over-read. It reports what the manufacturer measured on the powder at release. It does not establish any of the following.

• The microbial status of your finished product. A microbial limit on the raw material is a statement about the powder. Your water phase, your preservative and your filling line decide the finished product.
• Stability in your base. The COA is release data under the storage condition and until the retest date printed on it. Copper loss to a chelator, thiol oxidation, deamidation and photodegradation happen in your formula, not in the manufacturer's freezer.
• Claims. HPLC purity says the molecule is present. It says nothing about what a product containing it will do.
• Compatibility and use level. Whether the peptide tolerates your preservative, polymer or other actives is a bench question. The manufacturer reports identity and purity; the formulator sets the use level from their own stability and tolerance work.
• The status of the finished product. No raw-material document makes a product compliant. The file does.

Read the COA for what it is: the identity and purity of a specific lot, against a specific specification, on a specific date, under a stated storage condition.

Questions to ask a supplier

Ten questions that separate a listing that will support your file from one that will not. The answers should be short and documentary.

1. What INCI name and CAS number will appear on the lot COA, and does the CAS describe the material in the jar (for copper peptides: complex or free ligand)?
2. Which salt form and counter-ion is the material supplied as, and is the counter-ion reported?
3. Can you send a recent lot COA and the SDS before I order, and do they show the manufacturer's name and address?
4. Is the SDS in the GHS sixteen-section format and in a language my safety assessor reads?
5. What storage condition and retest date will be printed on my lot's COA?
6. Which tests beyond HPLC purity and MS identity can be reported if my specification asks: water content, residual solvents, heavy metals, microbial limits?
7. Is the material shipped cold-chain, and what are the minimum order and the typical lead time?
8. Are public batch records available so I can see lot-to-lot variation before I commit?
9. Does the listing or the paperwork carry any medical positioning I would have to explain away in my file?
10. Is the seller the manufacturer, and if not, who is?

For the compounds on this site: lot COA and SDS on request for every shipment, manufacturer Pepti, Guangzhou on both documents, bulk powder from 5 g, cold-chain shipping, lead time typically 3–7 days for a sample or small lot.

Maintained by Pepti, a Guangzhou peptide manufacturer. Batch records referenced on this site are published at peptioem.com/coa. Last reviewed 2026-10-19.